Catalog Home Page

Panton–Valentine leukocidin-positive Staphylococcus aureus: A position statement from the International Society of Chemotherapy

Saeed, K., Gould, I., Espositio, S., Ahmad-Saeed, N., Ahmed, S.S., Alp, E., Bal, A.M., Bassetti, M., Bonnet, E., Chan, M., Coombs, G., Dancer, S.J., David, M.Z., De Simone, G., Dryden, M., Guardabassi, L., Hanitsch, L.G., Hijazi, K., Krüger, R., Lee, A., Leistner, R., Pagliano, P., Righi, E., Schneider-Burrus, S., Skov, R.L., Tattevin, P., Van Wamel, W., Vos, M.C. and Voss, A. (2017) Panton–Valentine leukocidin-positive Staphylococcus aureus: A position statement from the International Society of Chemotherapy. International Journal of Antimicrobial Agents, 51 (1). pp. 16-25.

[img]
PDF - Authors' Version
Embargoed until January 2019.

Link to Published Version: https://doi.org/10.1016/j.ijantimicag.2017.11.002
*Subscription may be required

Abstract

Panton–Valentine leukocidin (PVL), a pore-forming cytotoxic secreted toxin, has been associated with severe Staphylococcus aureus pneumonia and prototypical skin lesions. The reported incidence and prevalence of PVL-positive S. aureus (PVLP-SA) varies globally and suffers from a selective reporting bias towards community-associated methicillin-resistant S. aureus (CA-MRSA)...

Publication Type: Journal Article
Murdoch Affiliation: School of Veterinary and Life Sciences
Publisher: Elsevier
Copyright: © 2017 Elsevier B.V.
URI: http://researchrepository.murdoch.edu.au/id/eprint/39896
Item Control Page Item Control Page